Chip Moebus

Chip Moebus currently serves as the Vice President of Market Access at Epiminder, starting in May 2024, where responsibilities include establishing the US commercial organization for a continuous sub-scalp EEG monitoring system aimed at aiding epilepsy patients. Previously, Chip Moebus held the position of Vice President of Reimbursement & Market Access at Mainstay Medical from June 2020 to May 2024, leading strategies for a neurostimulation technology addressing chronic low back pain. Prior roles include Head of Reimbursement & Market Access at Senseonics, Incorporated, and Director of Reimbursement & Market Access at Medtronic, where strategic development and execution were focused on various healthcare technologies. Early career positions included sales and account management roles at Daiichi Sankyo and Novartis. Chip Moebus holds a degree in Microbiology and Cell Science, with a minor in Chemistry, from the University of Florida.